Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹175.45Prev. Close
₹172.85Turnover(Lac.)
₹28.33Day's High
₹177Day's Low
₹16652 Week's High
₹218.852 Week's Low
₹118.9Book Value
₹60.81Face Value
₹10Mkt Cap (₹ Cr.)
192.01P/E
53.42EPS
3.14Divi. Yield
0.8920 May 2023
12:00 AM
Dividend
Dividend Amount: 2
Record Date: 28 Jul, 2023
20 May 2023
12:00 AM
AGM
Announcement Date: 20 May, 2023
20 May 2023
12:00 AM
BookCloser
26 Apr 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 11.45 | 11.45 | 11.45 | 3.82 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 56.71 | 55.72 | 49.05 | 38.65 |
Net Worth | 68.16 | 67.17 | 60.5 | 42.47 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Revenue | 133.37 | 126.5 | 131.07 | 137.41 |
yoy growth (%) | 5.43 | -3.48 | -4.61 | 41.16 |
Raw materials | -80.06 | -66.45 | -83.48 | -90.54 |
As % of sales | 60.02 | 52.53 | 63.69 | 65.89 |
Employee costs | -13.72 | -11.79 | -13.57 | -12.85 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Profit before tax | 13.77 | 24.05 | 12.09 | 9.75 |
Depreciation | -4.25 | -3.94 | -4.38 | -4.13 |
Tax paid | -3.38 | -6.94 | -3.64 | -2.89 |
Working capital | -2.89 | 13.73 | -4.58 | 4.57 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 5.43 | -3.48 | -4.61 | 41.16 |
Op profit growth | -35.41 | 87.26 | -8.16 | 409.08 |
EBIT growth | -41.32 | 64.67 | 14.5 | -2,333.94 |
Net profit growth | -39.31 | 102.52 | 23.1 | -313.53 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,523 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,563.6 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,482.2 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,090.5 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,477.65 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
E Purushotham
Joint Managing Director & CFO
E Swapnil
Independent Director
J H Ranade
Independent Director
K Ramaswamy
Independent Director
Kashinath R Dhole
Company Sec. & Compli. Officer
Urvashi D Khanna
Non-Exec & Non-Independent Dir
E. Smruthi
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Smruthi Organics Ltd
Summary
Smruthi Organics Ltd was incorporated in July, 1989 as a private limited company and was subsequently converted into a public limited company in February, 1995. It was promoted by E Purushotham and Shankarrao R Myakal. The Company is a manufacturer of Active Pharmaceutical Ingredient (API) products in the Anti - Diabetic, Anti - Hypertension and Anti - Infectives Therapeutic categories catering to both the Indian domestic as well as rest of the world (ROW) markets, with clients spanning across Asia, Americas, and Africa. It has 2 manufacturing facilities in Solapur, India. The company set up a plant at Solapur, Maharashtra, to manufacture bulk drugs like diloxanide furoate (inst. cap. : 24 tpa) and sulphadiazine (inst. cap. : 36 tpa). It expanded its activities and product range in 1993-94 by manufacturing metronidazole benzoate, tinidazole, paracetamol and norfloxacin. The company exports furoic acid to the UK market. In 1995, it proposed to expand its product range and set up an additional plant at Chincholi, Maharashtra, for the manufacture of additional bulk drugs like ciprofloxacin and ranitidine HCl. The company issued shares to the public in Dec.95, to part-finance the project.In 1993, the company received the district award as the Best Small Scale Entrepreneur in Solapur in the Year 1993, from the Government of Maharashtra.In 2011-12, the Companys expansion project became commercialized from 21st September 2012. In 2021-22, the Companys Finished Dosage Formulatio
Read More
What is the Smruthi Organics Ltd share price today?
The Smruthi Organics Ltd shares price on nse is Rs.₹167.75 today.
What is the Market Cap of Smruthi Organics Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Smruthi Organics Ltd is ₹192.01 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Smruthi Organics Ltd?
The PE and PB ratios of Smruthi Organics Ltd is 53.42 and 2.76 as of 03 Jul ‘24
What is the 52 Week High and Low of Smruthi Organics Ltd?
The 52-week high/low is the highest and lowest price at which a Smruthi Organics Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Smruthi Organics Ltd is ₹118.9 and ₹218.8 as of 03 Jul ‘24
What is the CAGR of Smruthi Organics Ltd?
Smruthi Organics Ltd's CAGR for 5 Years at 29.03%, 3 Years at -18.13%, 1 Year at 36.64%, 6 Month at 1.83%, 3 Month at 11.95% and 1 Month at 2.95%.
What is the shareholding pattern of Smruthi Organics Ltd?
The shareholding pattern of Smruthi Organics Ltd is as follows:
Promoters - 63.84 %
Institutions - 0.00 %
Public - 36.16 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
